Results 161 to 170 of about 74,631 (338)

Informed Consent Procedure for Research Including Patients with Parkinson's Disease and Cognitive Impairment

Movement Disorders Clinical Practice, EarlyView.
Vibuthi Sisodia, Bart E.K.S. Swinnen, Evelien Lemstra, Gert J. Geurtsen, Albert F.G. Leentjens, Martin A.J.M. Buijsen, Maartje H.N. Schermer, Rob M.A. de Bie   +7 more
wiley   +1 more source

Comparison of the clinical pharmacology of (-)NPA and levodopa in Parkinson's disease. [PDF]

, 1991
M. Maral Mouradian, Isabella J.E. Heuser, Fabio Baronti, Marianne Giuffra, Kathy Conant, Thomas L. Davis, Thomas N. Chase   +6 more
openalex   +1 more source

Levodopa [PDF]

, 2011
openaire   +1 more source

Levodopa‐Carbidopa Intestinal Gel Improves Dyskinesia in Parkinson's Disease: Post Hoc Analysis from the COSMOS Study

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Dyskinesia is a debilitating complication of dopaminergic therapy in advanced Parkinson's disease. Objectives To evaluate the effect of levodopa‐carbidopa intestinal gel (LCIG) on dyskinesia burden. Methods This is a post hoc analysis of the retrospective, observational COmedication Study assessing Mono‐ and cOmbination therapy with
Alfonso Fasano, Cleanthe Spanaki, Tanya Gurevich, Robert Jech, Per Svenningsson, József Szász, Lydia Vela‐Desojo, Mihaela Simu, Lars Bergmann, Abdallah Saad, Juan Carlos Parra, Norbert Kovács   +11 more
wiley   +1 more source

Spectrophotometric Determination of Catecholamines Via Charge Transfer Complexation with Bromanil, Applications to Catecholamine Drug Formulations

Science Journal of University of Zakho, 2013
A simple, sensitive, rapid and low-cost spectrophotometric method for catecholamine (levodopa, methyldopa and dopamine) determination in pure and drug formulations is described.
MAHMOOD A. HASAN
doaj  

Deep Brain Stimulation in Classical Galactosemia: A Case‐Report

Movement Disorders Clinical Practice, EarlyView.
Nolwenn Billet, Emile Simon, Chloé Laurencin, Adelaide Jaulent, Paul Jaulent, Teodor Danaila, Stephane Prange, Stephane Thobois   +7 more
wiley   +1 more source

Investigation of the Determinants of Disease Severity in Patients with Idiopathic Normal Pressure Hydrocephalus

Movement Disorders Clinical Practice, EarlyView.
Background The determinants of the severity of idiopathic normal pressure hydrocephalus (iNPH) have not been examined previously. Objective To reveal the clinical determinants of the clinical severity of iNPH in detail. To provide some clinical remarks and contributions to the understanding of the pathophysiology.
Halil Onder, Ahmet Gunaydin, Nursu Erdogan, Selcuk Comoglu   +3 more
wiley   +1 more source

Opicapone in Parkinson's Disease on Levodopa‐Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Levodopa‐carbidopa intestinal gel infusion (LCIG) is an effective therapy for advanced Parkinson's disease (PD). Opicapone (OPC) is an enzyme inhibitor that enhances the bioavailability of levodopa in the brain. Objectives This study evaluates the effect of Opicapone addition in PD‐LCIG patients, assessing its impact on motor ...
Fabiana Colucci, Andrea Gozzi, Pietro Antenucci, Ilaria Casetta, Lorenza Maistrello, Annibale Antonioni, Emanuela Maria Raho, Ginevra Tecilla, Jay Guido Capone, Mariachiara Sensi   +9 more
wiley   +1 more source

Augmenting the action of levodopa

, 1972
Sumant Rao, S. D. Vakil, Donald B. Calne, A. J.W. Hilson   +3 more
openalex   +1 more source

A Double-Blind, Placebo-Controlled Study of the Treatment of Periodic Limb Movements in Sleep Using Carbidopa/Levodopa and Propoxyphene [PDF]

, 1993
Peter W. Kaplan, Richard P. Allen, David W. Buchholz, J. Ken Walters   +3 more
openalex   +1 more source